HbA1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline
We compared the utility of glycated haemoglobin (HbA1c) and oral glucose tolerance (oGTT) in non-diabetic patients for identifying incident diabetes; all-cause mortality; cardiovascular disease (CVD) mortality; CVD, coronary heart disease (CHD), and ischaemic stroke events; and diabetes microvascular complications.Methods: Data from a New Zealand community setting were prospectively linked to hospitalization, mortality, pharmaceutical and laboratory test results data. After applying exclusion criteria (prior laboratory diagnosis or history of drug treatment for diabetes or hospitalisation for diabetes or CVD event), there were 31,148 adults who had an HbA1c and 2-hr 75g oGTT.
Source: Journal of Diabetes and Its Complications - Category: Endocrinology Authors: PA. Metcalf, C. Kyle, T. Kenealy, S. Wells, RT. Jackson Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Diabetes | Endocrinology | Heart | Heart Disease | Ischemic Stroke | Laboratory Medicine | Stroke